快速检索
年期检索
摘要： Objective To study the core contents of the “Implementation Measures for Early Settlement Mechanism of Drug Patent Disputes (Trial)” in China, and to clarify the concerns for enterprises in future work. Methods A comprehensive review of the literature was used to find out the key regulations for detailed decomposition and analysis. Results and Conclusion By analyzing the key clauses of China’s “Implementation Measures for Early Settlement Mechanism of Drug Patent Disputes (Trial)”, some practical countermeasures and suggestions are put forward for related research and development (R&D) innovation and drug declaration of enterprises.
